{
  "document": "Foundation_39",
  "Genomic Findings": [
    {
      "Name": "PALB2 S254fs*3, splice site 3113+1G>A",
      "Clinical": ["Olaparib", "Talazoparib"],
      "No Clinical": ["Niraparib", "Rucaparib"]
    },
    { "Name": "GNA13 K42N - subclonal", "Clinical": [], "No Clinical": [] }
  ],
  "Biomakers findings": [
    {
      "Name": "Tumor Mutational Burden - 10 Mutations/Mb",
      "Clinical": ["Atezolizumab", "Pembrolizumab"],
      "No Clinical": [
        "Avelumab",
        "Cemiplimab",
        "Durvalumab",
        "Nivolumab",
        "Nivolumab + Ipilimumab"
      ]
    },
    {
      "Name": "Microsatellite status - MS-Stable",
      "Clinical": [],
      "No Clinical": []
    }
  ]
}